These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 15114750)
1. [Extracorporeal shock-wave therapy in the treatment of Peyronie's disease]. Neĭmark AI; Astakhov IuI; Sidor MV Urologiia; 2004; (2):33-5. PubMed ID: 15114750 [TBL] [Abstract][Full Text] [Related]
2. Shockwave therapy as first-line treatment for Peyronie's disease: a prospective study. Skolarikos A; Alargof E; Rigas A; Deliveliotis Ch; Konstantinidis E J Endourol; 2005; 19(1):11-4. PubMed ID: 15735375 [TBL] [Abstract][Full Text] [Related]
3. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial. Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227 [TBL] [Abstract][Full Text] [Related]
6. Shockwave Therapy in the Treatment of Peyronie's Disease. Krieger JR; Rizk PJ; Kohn TP; Pastuszak A Sex Med Rev; 2019 Jul; 7(3):499-507. PubMed ID: 30926460 [TBL] [Abstract][Full Text] [Related]
7. Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study. Hatzichristodoulou G; Meisner C; Gschwend JE; Stenzl A; Lahme S J Sex Med; 2013 Nov; 10(11):2815-21. PubMed ID: 23898925 [TBL] [Abstract][Full Text] [Related]
12. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach. Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898 [TBL] [Abstract][Full Text] [Related]
13. Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial. Chitale S; Morsey M; Swift L; Sethia K BJU Int; 2010 Nov; 106(9):1352-6. PubMed ID: 20438568 [TBL] [Abstract][Full Text] [Related]
14. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline). Lebret T; Loison G; Hervé JM; Mc Eleny KR; Lugagne PM; Yonneau L; Orsoni JL; Saporta F; Butreau M; Botto H Urology; 2002 May; 59(5):657-61. PubMed ID: 11992835 [TBL] [Abstract][Full Text] [Related]
15. Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience. Husain J; Lynn NN; Jones DK; Collins GN; O'Reilly PH BJU Int; 2000 Sep; 86(4):466-8. PubMed ID: 10971273 [TBL] [Abstract][Full Text] [Related]
16. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment? Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288 [TBL] [Abstract][Full Text] [Related]
17. The treatment of loss of penile rigidity associated with Peyronie's disease. Krane RJ Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682 [TBL] [Abstract][Full Text] [Related]
18. Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity. Strebel RT; Suter S; Sautter T; Hauri D Int J Impot Res; 2004 Oct; 16(5):448-51. PubMed ID: 14973523 [TBL] [Abstract][Full Text] [Related]